Showing 1 - 10 of 48
In US vaccine markets, competing producers with high fixed, sunk costs face relatively concentrated demand. The resulting price and quality competition leads to the exit of all but one or very few producers per vaccine. Our empirical analysis of exits from US vaccine markets supports the...
Persistent link: https://www.econbiz.de/10013122642
intentions on realized behavioral outcomes. The outcome of interest is influenza vaccination receipt at free on-site clinics … listed the times and locations of the relevant vaccination clinics. Mailings to employees randomly assigned to the treatment … and time the employee planned to be vaccinated. Vaccination rates increased when these implementation intentions prompts …
Persistent link: https://www.econbiz.de/10013122874
We argue that in pharmaceutical markets, variation in the arrival time of consumer heterogeneity creates differences between a producer's ability to extract consumer surplus with preventives and treatments, potentially distorting R&D decisions. If consumers vary only in disease risk, revenue...
Persistent link: https://www.econbiz.de/10013085502
Traditional economic models of vaccination assume that agents free-ride on the vaccination decision of others. These … models show that private vaccination rates are always below the social optimal and even large subsidies cannot achieve … conform to the vaccination decisions of their peers. In this model privately optimal vaccination rates can be higher or lower …
Persistent link: https://www.econbiz.de/10013074645
also document cross-vaccine spillovers: the mandates increased adolescent vaccination for meningococcal disease and human …
Persistent link: https://www.econbiz.de/10012964395
Health and Retirement Longitudinal Study), we assess the long-term effects of childhood vaccination on cognitive and … treatment on the treated effect of childhood vaccination. Our results confirm that vaccinations before the age of 15 have long …
Persistent link: https://www.econbiz.de/10012833122
Recent outbreaks of infectious pathogens such as Zika, Ebola, and COVID-19 have underscored the need for the dependable availability of vaccines against emerging infectious diseases (EIDs). The cost and risk of R&D programs and uniquely unpredictable demand for EID vaccines have discouraged...
Persistent link: https://www.econbiz.de/10012833126
A key driver in biopharmaceutical investment decisions is the probability of success of a drug development program. We estimate the probabilities of success (PoSs) of clinical trials for vaccines and other anti-infective therapeutics using 43,414 unique triplets of clinical trial, drug, and...
Persistent link: https://www.econbiz.de/10012833746
We extend the canonical epidemiology model to study the interaction between economic decisions and epidemics. Our model implies that people's decision to cut back on consumption and work reduces the severity of the epidemic, as measured by total deaths. These decisions exacerbate the size of the...
Persistent link: https://www.econbiz.de/10012838980
-mumps-rubella vaccine causes autism. A persistent trend to delay the vaccination during 1998–2011 in the US was driven by children of … vaccination decisions, suggesting that online dissemination of vaccine-safety information may help tackle the sticky …
Persistent link: https://www.econbiz.de/10012840852